[go: up one dir, main page]

WO2016060577A1 - A cigarette with cytisine - Google Patents

A cigarette with cytisine Download PDF

Info

Publication number
WO2016060577A1
WO2016060577A1 PCT/PL2015/000169 PL2015000169W WO2016060577A1 WO 2016060577 A1 WO2016060577 A1 WO 2016060577A1 PL 2015000169 W PL2015000169 W PL 2015000169W WO 2016060577 A1 WO2016060577 A1 WO 2016060577A1
Authority
WO
WIPO (PCT)
Prior art keywords
cigarette
cytisine
tobacco
cigarettes
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/PL2015/000169
Other languages
French (fr)
Inventor
Łukasz ZALEWSKI
Piotr ZALEWSKI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2016060577A1 publication Critical patent/WO2016060577A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10Chemical features of tobacco products or tobacco substitutes
    • A24B15/16Chemical features of tobacco products or tobacco substitutes of tobacco substitutes

Definitions

  • the subject of the invention is a cigarette with cytisine, a product of the tobacco industry made of processed material of organic origin, not containing tobacco, with an addition of the organic chemical compound with formula Q jHi4N 2 0 commonly known as cytisine.
  • Cigarettes manufactured nowadays have a characteristic form of a tube, made usually of a thin cigarette paper, containing ingredients decisive for its properties producing specific effect on central nervous system of the smoking person, the most important of the ingredients being tobacco.
  • Tobacco contains nicotine, among other things.
  • nicotine contained in smoke generated in the tobacco combustion process gets into blood and produces its effect on organism of the smoking person.
  • Nicotine has strong addictive properties and is a potent toxin.
  • tobacco smoke contains other harmful and carcinogenic chemical compounds. It is advisable to reduce content of these substances.
  • E-cigarettes made of plastics, house cartridges with a dose of nicotine released by a mechanism mounted inside a device imitating functional features of traditional cigarettes.
  • E-cigarettes neither contain any combustible plant material nor generate any cigarette smoke; however, they contain nicotine as well as aromatic substances.
  • Manufactured are also cigarettes not containing tobacco but herbs, tea, or leafs of other plants. Such cigarettes are very seldom a choice of smokers due to absence of nicotine content.
  • cytisine is administered in small doses in the form of tablets, as a nicotine substitute in mitigation of nicotine cravings in the course of therapies aimed at reduction of negative effects of nicotinism.
  • Cytisine demonstrates effects similar to those produced by nicotine, has a stimulating effect on autonomic nervous system, mainly the respiratory centre. It stimulates also the vasomotor centre, increases secretion of adrenaline, and results in an increase of blood pressure.
  • autonomic nervous system mainly the respiratory centre. It stimulates also the vasomotor centre, increases secretion of adrenaline, and results in an increase of blood pressure.
  • any solutions consisting in enriching organic substances with cytisine according to the method characterising the invention "A cigarette with cytisine" are not known.
  • a cigarette with cytisine is to provide cigarettes without tobacco, imitating features characteristic for cigarettes containing tobacco but containing other organic additives and cytisine in the dose from 0.000000001 mg to 10 mg.
  • This problem has been solved by combining substances of organic origin in the amount from 0.0001% to 100% of the air moisture free mass of the cigarette and a dose of cytisine in the amount from 0.000000001 mg to 10 mg in such a way that the added cytisine increases said mass and changes its properties, as a result of which a cigarette is obtained characterised in that it contains organic substances other than tobacco in the amount from 0.0001%» to 100% of the air moisture free mass of the cigarette and a dose of cytisine in the amount from 0.000000001 mg to 10 mg.
  • cytisine is placed within the mass of cigarette: in its paper tube, filter, combustible cartridge or conglomerate placed in the paper tube containing also a processed material of organic origin, however not containing tobacco leaves.
  • cigarettes are obtained made of processed organic substances other than tobacco, containing cytisine and with a number of traditional features of cigarettes maintained.
  • a distinctive quality of the solution with respect to other known solutions is combination of a given quantity of cytisine with structural components of cigarette in a single product with features and appearance of a cigarette in such a way that, unlike traditional cigarettes, it does not contain tobacco, containing instead a measured dose of cytisine.
  • Intermediate products in the manufacturing process are: an organic material not containing tobacco processed according to any formula used by tobacco industry manufacturers and cytisine of organic origin and/or prepared synthetically, as a result of genetic modification, or through a combination of these processes.
  • a cigarette formed according to design solutions known and used in the tobacco industry and more precisely, in its paper envelope in the form of a tube or other geometrical form tipped with a filter or not, or in the filter playing the role of mouthpiece, or in the organic combustible mass contained in the cigarette paper tube, or in any other portion of cigarette and in any number of its elements and components, the chemical compound known as cytisine is placed in any amount, however not exceeding in total the dose according to the formula characterising the invention and defined as 10 milligrams per cigarette.
  • the method of application of cytisine according to the invention is:
  • Cytisine is placed— at the same time in each structural component of cigarette or separately in any stractural components thereof such as filter, mouthpiece and/or combustible portion of cigarette constituting the cigarette paper tube or its content— as a granulate, powder, emulsion, suspension, solution, deposit, material, conglomerate and/or mixture of intermediate products in arbitrary proportions, by means of direct application in the course of combustion of the cigarette and/or in the course of the stage of manufacturing the cigarette and/or intem ediate products used in the tobacco industry by means of admixing, saturating, gassing and/or adding by any combination of such processes a measured dose of a substance containing in its composition a measured dose of cytisine and/or pure cytisine and/or other substances processed in the course of the manufacturing process or before it, as a result of chemical reactions, physical processes, genetic modifications, or any combination thereof.
  • Placing cytisine in a cigarette can be accomplished in the process of manufacturing cigarette filters, cigarette paper tubes, or organic material contained in rolling paper, filters, or other cigarette components and inserts which, after application of cytisine thereto, are subject to seasoning and manufacturing processes specific to forming cigarettes and/or intermediate products thereof.
  • Cytisine can be also placed in a finished cigarette made of organic mass not containing tobacco in the course of last stage of the cigarette manufacturing process, and even after forming the cigarette as the finished product.
  • a cigarette is subject to processing described above aimed at enriching it with a measured dose of cytisine, and then seasoned.
  • Cigarettes manufactured according to the invented method and used to generate and inhale smoke share a number of organoleptic qualities with traditional cigarettes containing tobacco leafs, such as giving off a smoke, smouldering, producing heat, producing a characteristic taste and aroma composition, and, additionally, allow to release cytisine of organic origin or obtained synthetically to be released in the process of combustion of substances of organic origin.
  • a dose of cytisine ranging from 0.000000001 milligrams to 10 milligrams contained in the smoke is released from organic substances, gets into blood, and produces its effect on organism of the smoking person.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cigarettes, Filters, And Manufacturing Of Filters (AREA)
  • Manufacture Of Tobacco Products (AREA)

Abstract

A cigarette with cytisine according to invention is characterised in that it contains organic substances other than tobacco in the amount from 0.0001% to 100% of the air moisture free mass of the cigarette and a dose of cytisine in the amount from 0.000000001 milligram to 10 milligrams.

Description

"A cigarette with cytisine"
The subject of the invention is a cigarette with cytisine, a product of the tobacco industry made of processed material of organic origin, not containing tobacco, with an addition of the organic chemical compound with formula Q jHi4N20 commonly known as cytisine.
In the current state of the art, the tobacco industiy manufactures numerous variations of cigarettes used for smoking and inhaling, containing processed plants of tobacco species called commonly the tobacco. Cigarettes manufactured nowadays have a characteristic form of a tube, made usually of a thin cigarette paper, containing ingredients decisive for its properties producing specific effect on central nervous system of the smoking person, the most important of the ingredients being tobacco.
Tobacco contains nicotine, among other things. In the course of cigarette smoking, nicotine contained in smoke generated in the tobacco combustion process gets into blood and produces its effect on organism of the smoking person. Nicotine has strong addictive properties and is a potent toxin. Apart from nicotine, tobacco smoke contains other harmful and carcinogenic chemical compounds. It is advisable to reduce content of these substances.
Known are also e-cigarettes made of plastics, house cartridges with a dose of nicotine released by a mechanism mounted inside a device imitating functional features of traditional cigarettes. E-cigarettes neither contain any combustible plant material nor generate any cigarette smoke; however, they contain nicotine as well as aromatic substances. Manufactured are also cigarettes not containing tobacco but herbs, tea, or leafs of other plants. Such cigarettes are very seldom a choice of smokers due to absence of nicotine content.
In order to reduce the negative effects produced by tobacco on the organism of a smoker it is desirable to develop effective products that could be used as diet supplement for the purpose of the nicotine substitution therapy or other tobacco industry products with low toxicity. Currently, cytisine is administered in small doses in the form of tablets, as a nicotine substitute in mitigation of nicotine cravings in the course of therapies aimed at reduction of negative effects of nicotinism.
Cytisine demonstrates effects similar to those produced by nicotine, has a stimulating effect on autonomic nervous system, mainly the respiratory centre. It stimulates also the vasomotor centre, increases secretion of adrenaline, and results in an increase of blood pressure. At present, any solutions consisting in enriching organic substances with cytisine according to the method characterising the invention "A cigarette with cytisine" are not known.
The objective of the invention "A cigarette with cytisine" is to provide cigarettes without tobacco, imitating features characteristic for cigarettes containing tobacco but containing other organic additives and cytisine in the dose from 0.000000001 mg to 10 mg.
This problem has been solved by combining substances of organic origin in the amount from 0.0001% to 100% of the air moisture free mass of the cigarette and a dose of cytisine in the amount from 0.000000001 mg to 10 mg in such a way that the added cytisine increases said mass and changes its properties, as a result of which a cigarette is obtained characterised in that it contains organic substances other than tobacco in the amount from 0.0001%» to 100% of the air moisture free mass of the cigarette and a dose of cytisine in the amount from 0.000000001 mg to 10 mg.
In the technological process of manufacturing cigarettes according to the invention, cytisine is placed within the mass of cigarette: in its paper tube, filter, combustible cartridge or conglomerate placed in the paper tube containing also a processed material of organic origin, however not containing tobacco leaves. This way, cigarettes are obtained made of processed organic substances other than tobacco, containing cytisine and with a number of traditional features of cigarettes maintained. A distinctive quality of the solution with respect to other known solutions is combination of a given quantity of cytisine with structural components of cigarette in a single product with features and appearance of a cigarette in such a way that, unlike traditional cigarettes, it does not contain tobacco, containing instead a measured dose of cytisine. Intermediate products in the manufacturing process are: an organic material not containing tobacco processed according to any formula used by tobacco industry manufacturers and cytisine of organic origin and/or prepared synthetically, as a result of genetic modification, or through a combination of these processes.
An embodiment of the solution according to the invention is described in the following as an example process of producing a single cigarette with cytisine:
In a cigarette formed according to design solutions known and used in the tobacco industry, and more precisely, in its paper envelope in the form of a tube or other geometrical form tipped with a filter or not, or in the filter playing the role of mouthpiece, or in the organic combustible mass contained in the cigarette paper tube, or in any other portion of cigarette and in any number of its elements and components, the chemical compound known as cytisine is placed in any amount, however not exceeding in total the dose according to the formula characterising the invention and defined as 10 milligrams per cigarette. The method of application of cytisine according to the invention:
Cytisine is placed— at the same time in each structural component of cigarette or separately in any stractural components thereof such as filter, mouthpiece and/or combustible portion of cigarette constituting the cigarette paper tube or its content— as a granulate, powder, emulsion, suspension, solution, deposit, material, conglomerate and/or mixture of intermediate products in arbitrary proportions, by means of direct application in the course of combustion of the cigarette and/or in the course of the stage of manufacturing the cigarette and/or intem ediate products used in the tobacco industry by means of admixing, saturating, gassing and/or adding by any combination of such processes a measured dose of a substance containing in its composition a measured dose of cytisine and/or pure cytisine and/or other substances processed in the course of the manufacturing process or before it, as a result of chemical reactions, physical processes, genetic modifications, or any combination thereof.
Placing cytisine in a cigarette can be accomplished in the process of manufacturing cigarette filters, cigarette paper tubes, or organic material contained in rolling paper, filters, or other cigarette components and inserts which, after application of cytisine thereto, are subject to seasoning and manufacturing processes specific to forming cigarettes and/or intermediate products thereof.
Cytisine can be also placed in a finished cigarette made of organic mass not containing tobacco in the course of last stage of the cigarette manufacturing process, and even after forming the cigarette as the finished product. In such case, a cigarette is subject to processing described above aimed at enriching it with a measured dose of cytisine, and then seasoned.
Cigarettes manufactured according to the invented method and used to generate and inhale smoke share a number of organoleptic qualities with traditional cigarettes containing tobacco leafs, such as giving off a smoke, smouldering, producing heat, producing a characteristic taste and aroma composition, and, additionally, allow to release cytisine of organic origin or obtained synthetically to be released in the process of combustion of substances of organic origin. Like in a traditional tobacco-containing cigarette, in the course of combustion of the processed material of organic origin enriched with cytisine, a dose of cytisine ranging from 0.000000001 milligrams to 10 milligrams contained in the smoke is released from organic substances, gets into blood, and produces its effect on organism of the smoking person.

Claims

Patent claims
A cigarette characterised in that it contains organic substances other than tobacco in the amount from 0.0001% to 100% of the air moisture free mass of the cigarette and a dose of cytisine in the amount from 0.000000001 milligram to 10 milligrams.
PCT/PL2015/000169 2014-10-18 2015-10-16 A cigarette with cytisine Ceased WO2016060577A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PLP.409830 2014-10-18
PL409830A PL409830A1 (en) 2014-10-18 2014-10-18 Cigarette with cytisine

Publications (1)

Publication Number Publication Date
WO2016060577A1 true WO2016060577A1 (en) 2016-04-21

Family

ID=54884357

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/PL2015/000169 Ceased WO2016060577A1 (en) 2014-10-18 2015-10-16 A cigarette with cytisine

Country Status (2)

Country Link
PL (1) PL409830A1 (en)
WO (1) WO2016060577A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108140664A (en) * 2017-04-19 2018-06-08 歌尔股份有限公司 Micro light emitting diode array transfer method, manufacturing method and display device
US10300050B2 (en) 2016-02-05 2019-05-28 Achieve Pharma Uk Limited Succinate salt of cytisine and use thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1201142A1 (en) * 2000-10-27 2002-05-02 Jan Raes Method to stop smoking
US20060243290A1 (en) * 2003-10-02 2006-11-02 Susan Reich Tobacco product labeling system

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1201142A1 (en) * 2000-10-27 2002-05-02 Jan Raes Method to stop smoking
US20060243290A1 (en) * 2003-10-02 2006-11-02 Susan Reich Tobacco product labeling system

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10300050B2 (en) 2016-02-05 2019-05-28 Achieve Pharma Uk Limited Succinate salt of cytisine and use thereof
CN108140664A (en) * 2017-04-19 2018-06-08 歌尔股份有限公司 Micro light emitting diode array transfer method, manufacturing method and display device
CN108140664B (en) * 2017-04-19 2023-04-14 歌尔股份有限公司 Micro light emitting diode array transfer method, manufacturing method and display device

Also Published As

Publication number Publication date
PL409830A1 (en) 2016-04-25

Similar Documents

Publication Publication Date Title
RU2593362C2 (en) Nicotine replacement cytisine oral atomised liquid and method of its preparation
WO2016060576A1 (en) A liquid with cytisine for electronic cigarettes
JP6989151B2 (en) Smoking goods
BG63420B1 (en) Tobacco products with filters or tobacco-like products with filters of natural substances with anti-oxidant effect and their production
CN103005696A (en) Agilawood cigar and preparation method thereof
RS58457B1 (en) Tobacco substitute
JP7148756B2 (en) Articles and formulations for smoking products and vaporizers
JPH08505051A (en) Filter cigarette
CN113519888A (en) Electronic atomized liquid
Sakthisankaran et al. Health Risks Associated with Tobacco Consumption in Humans: An Overview.
WO2016060577A1 (en) A cigarette with cytisine
CN105672030A (en) Aroma-enhanced cigarette paper coated with compound natural herbal flavor and preparation method of cigarette paper
KR200412339Y1 (en) Low nicotine tobacco
NL2014099B1 (en) Cigarette filter.
US20030131857A1 (en) Nicotine free cigarette substitute
CN103919267B (en) A kind of preparation method of novel tobacco goods
CN103919269B (en) A kind of electronic cigarette
CN106376971A (en) Cigarette with cut tobaccos being cut reconstituted tobaccos and cut tobacco stems
Ray Effects of nicotine on sperm health and semen quality: a review based on animal studies
Górski Are e-cigarettes good or bad?
CN100512689C (en) Additive for lowering tar and free radical content in cigarette smoke and its adding method
PL223239B1 (en) C-cigarette
KR102013417B1 (en) Composition for herbal cigarettes and manufacturing method threrof
JP3068084B1 (en) Tobacco substitute composition
RU2346628C1 (en) Smoking mixture

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15813142

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15813142

Country of ref document: EP

Kind code of ref document: A1